Technology

ShockWave Medical

$129.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.51 (-1.15%) Today
$0.00 (0.00%) As of 10:14 AM UTC after-hours

Why Robinhood?

You can buy or sell SWAV and other stocks, options, and ETFs commission-free!

About SWAV

Shockwave Medical, Inc. operates as a medical device company. It focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA. The listed name for SWAV is ShockWave Medical, Inc. Common Stock.

CEO
Douglas Evan Godshall
Employees
284
Headquarters
Santa Clara, California
Founded
2009
Market Cap
4.48B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
493.21K
High Today
$131.21
Low Today
$129.05
Open Price
$130.50
Volume
230.42K
52 Week High
$143.79
52 Week Low
$22.01

Collections

SWAV Earnings

-$0.62
-$0.41
-$0.21
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Feb 17, After Hours

You May Also Like

PKBK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure